Duloxetine Uses in Patients With Kidney Disease: Different Recommendations From the United States Versus Europe and Canada

Am J Ther. 2019 Jul/Aug;26(4):e516-e519. doi: 10.1097/MJT.0000000000000737.
No abstract available

Publication types

  • Comparative Study
  • Editorial

MeSH terms

  • Canada
  • Depression / complications
  • Depression / drug therapy*
  • Diabetic Neuropathies / complications
  • Diabetic Neuropathies / drug therapy*
  • Duloxetine Hydrochloride / therapeutic use*
  • Europe
  • Humans
  • Medication Adherence
  • Practice Guidelines as Topic
  • Renal Insufficiency, Chronic / complications*
  • Serotonin and Noradrenaline Reuptake Inhibitors / therapeutic use*
  • United States

Substances

  • Serotonin and Noradrenaline Reuptake Inhibitors
  • Duloxetine Hydrochloride